Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Farmers Insurance
US Department of Justice
Medtronic
Cipla

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 9,988,437

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,988,437
Title:Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use
Abstract: Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (F) protein of Respiratory Syncytial Virus (RSV). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease. Methods of generating antibodies that immunospecifically bind RSV F protein also are provided.
Inventor(s): Williamson; Robert Anthony (London, GB), Wadia; Jehangir (San Diego, CA), Pascual; Gabriel (San Diego, CA), Keogh; Elissa (San Diego, CA)
Assignee: Janssen Vaccines & Prevention B.V. (Leiden, NL)
Application Number:15/077,558
Patent Claims:see list of patent claims

Details for Patent 9,988,437

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Medimmune SYNAGIS palivizumab VIAL 103770 002 1998-06-19 ➤ Sign Up Janssen Vaccines & Prevention B.V. (Leiden, NL) ➤ Sign Up RX search
Medimmune SYNAGIS palivizumab VIAL 103770 001 1998-06-19 ➤ Sign Up Janssen Vaccines & Prevention B.V. (Leiden, NL) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,988,437

Country Patent Number Publication Date
South Africa 201208546 Dec 19, 2018
World Intellectual Property Organization (WIPO) 2011020079 Feb 17, 2011
World Intellectual Property Organization (WIPO) 2012006596 Apr 19, 2012
World Intellectual Property Organization (WIPO) 2012006596 Jan 12, 2012
United States of America 2011076268 Mar 31, 2011
United States of America 2013177573 Jul 11, 2013
United States of America 2014044719 Feb 13, 2014
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Teva
Argus Health
Fuji
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.